Skip to content
healthcare.dev

Methotrexate

NDC 61703-161, Methotrexate, injection, solution, from Hospira, Inc..

Product NDC
61703-161
Status
Listed
Labeler
Hospira, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA011719
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61703-161 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOTREXATE SODIUM25 mg/mL

Pharmacologic classes

Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]

Package NDCNDC-11Package
61703-161-05617030161055 VIAL, MULTI-DOSE in 1 CARTON (61703-161-05) / 2 mL in 1 VIAL, MULTI-DOSE (61703-161-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bd287e89-32f9-4396-95fa-4b562869f476
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=61703-161
  • NADAC price for package 61703016105

    GET /v1/drugs/nadac/61703016105

Use it

Look up 61703-161 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61703-161 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61703-161. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.